tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Phase 1 Data and Strong Financial Position Justify Buy Rating for Precision BioSciences’ PBGENE-HBV
PremiumRatingsPromising Phase 1 Data and Strong Financial Position Justify Buy Rating for Precision BioSciences’ PBGENE-HBV
2M ago
Precision BioSciences reports safety, efficacy data for ELIMINATE-B trial cohort
Premium
The Fly
Precision BioSciences reports safety, efficacy data for ELIMINATE-B trial cohort
2M ago
Precision BioSciences Reports Promising Phase 1 Trial Results
Premium
Company Announcements
Precision BioSciences Reports Promising Phase 1 Trial Results
2M ago
Precision granted Rare Pediatric Disease Designation for PBGENE-DMD
PremiumThe FlyPrecision granted Rare Pediatric Disease Designation for PBGENE-DMD
3M ago
Precision BioSciences: Promising Gene Editing Platform Targets Chronic HBV and DMD with Strategic Focus
Premium
Ratings
Precision BioSciences: Promising Gene Editing Platform Targets Chronic HBV and DMD with Strategic Focus
3M ago
Precision BioSciences Holds Annual Stockholder Meeting
Premium
Company Announcements
Precision BioSciences Holds Annual Stockholder Meeting
4M ago
Precision BioSciences reports Q1 EPS ($2.21), consensus ($2.42)
PremiumThe FlyPrecision BioSciences reports Q1 EPS ($2.21), consensus ($2.42)
5M ago
Precision BioSciences reports Q1 EPS ($2.21), consensus ($2.42)
Premium
The Fly
Precision BioSciences reports Q1 EPS ($2.21), consensus ($2.42)
5M ago
Precision BioSciences Accelerates PBGENE-DMD Program for DMD
Premium
Company Announcements
Precision BioSciences Accelerates PBGENE-DMD Program for DMD
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100